NexgenRx Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was CAD 2.405 million compared to CAD 2.359 million a year ago. Net income was CAD 479,104 compared to net loss of CAD 34,938 a year ago. Basic earnings per share from continuing operations was CAD 0.007. For the half year, total revenue was CAD 5.279 million compared to CAD 4.742 million a year ago. Net income was CAD 763,695 compared to CAD 73,039 a year ago. Basic earnings per share from continuing operations was CAD 0.011 compared to CAD 0.001 a year ago.